Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder

BMC Medical Research Methodology

Volumn 10, Issue , 2010, Pages

  Arano, Ichiro ^a,b   Sugimoto, Tomoyuki ^b   Hamasaki, Toshimitsu ^b   Ohno, Yuko ^b  

^a PFIZER INC   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; HUMAN; MAJOR DEPRESSION; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK; STATISTICS; SURVIVAL; TREATMENT WITHDRAWAL;

ALGORITHMS; DEPRESSIVE DISORDER, MAJOR; HUMANS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RESEARCH DESIGN; RISK; SURVIVAL ANALYSIS; WITHHOLDING TREATMENT;

EID: 77951101395     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-10-33     Document Type: Article

References (24)

1. Escitalopram continuation treatment prevents relapse of depressive episodes. MH Rapaort A Bose H Zheng, J Clin Psychiatry 2004 65 44 49 10.4088/JCP.v65n0107
2. Relapse prevention with Gepirone ER in outpatients with major depression. MB Keller FJL Ruwe CJJG Janssens JMAD Sitsen R Jokinen J Janczewski, J Clin Psychiatry 2005 25 79 84
3. A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan. K Kamijima T Burt G Cohen I Arano T Hamasaki, Int Clin Psychopharmacol 2006 21 1 9 10.1097/01.yic.0000182118.57510.d1 16317311
4. Duloxetine in the prevention of relapse of major depressive disorder: Double-blind placebo-controlled study. DG Perahia I Gilaberte F Wang CG Wiltse SA Huckins JW Clemens SA Montgomery AL Montejo MJ Detke, Br J Psychiatry 2006 188 346 353 10.1192/bjp.188.4.346 16582061
5. Prevention of recurrent episodes of depression with Venlafaxine ER in a 1-Year maintenance phase from the PREVENT study. JH Kocsis ME Thase MH Trivedi RC Shelton SG Kornstein CB Nemeroff ES Friedman AJ Gelenberg DL Dunner RMA Hirschfeld AJ Rothschild JM Ferguson AF Schatzberg JM Zajecka RD Pedersen B Yan S Ahmed J Musgnung PT Ninan MB Keller, J Clin Psychiatry 2007 68 1014 1023 10.4088/JCP.v68n0706 17685736
6. L Breiman JH Freidman RA Olshen CJ Stone, Classification and Regression Trees Belmont, CA: Wadsworth 1984
7. A mixture model combining logistic regression and proportional hazards regression. AYC Kuk CH Chen, Biometrika 1992 79 531 541 10.1093/biomet/79.3.531
8. Adjustment of the proportional hazards model via characteristics of cases and its inference. T Sugimoto M Goto, Bull Comput Statist Jpn 1999 12 85 106 (in Japanese)
9. A nonparametric mixture model for cure rate estimation. Y Peng KBG Dear, Biometrics 2000 56 237 243 10.1111/j.0006-341X.2000.00237.x 10783801
10. Estimation in a Cox proportional hazards cure model. JP Sy JMG Taylor, Biometrics 2000 56 227 236 10.1111/j.0006-341X.2000.00227.x 10783800
11. On semiparametric transformation cure models. W Lu Z Ying, Biometrika 2004 91 331 343 10.1093/biomet/91.2.331 (Pubitemid 41309915)
12. Estimation from pseudo partial likelihood in a semi-parametric cure model. T Sugimoto T Hamasaki M Goto, Journal of the Japanese Society of Computational Statistics 2005 18 1 33 46
13. Properties of estimators for baseline hazard functions in a semi-parametric cure model. T Sugimoto T Hamasaki, Ann Inst Statist Math 2006 58 647 674 10.1007/s10463-006-0041-0 (Pubitemid 44876605)
14. Regression trees for censored data. MR Segal, Biometrics 1988 44 35 48 10.2307/2531894
15. Maximum likelihood estimations of the proportion of patients cured by cancer therapy. JW Boag, J Roy Statist Soc 1949 B11 15 53
16. Semi-parametric estimation in failure time mixture models. JMG Taylor, Biometrics 1995 51 899 907 10.2307/2532991 7548707
17. Contribution to discussion of D.R. Cox (1972). NE Breslow, J Roy Statist Soc 1972 B11 15 53
18. Heuristics of instability and stabilization in model selection. L Breiman, Ann Statist 1996 24 2350 2383 10.1214/aos/1032181158
19. Identifiability of cure models. CS Li JMG Taylor JP Sy, Stat Prob Lett 2001 54 389 395 10.1016/S0167-7152(01)00105-5 (Pubitemid 33619115)
20. A new look at the statistical model identification. H Akaike, IEEE Tran Auto Cont 1974 19 716 723 10.1109/TAC.1974.1100705
21. Gender differences in the short-term course of unipolar depression in a follow-up sample of depressed inpatients. C Kuehner, J Affect Disord 1999 56 127 139 10.1016/S0165-0327(99)00035-X 10701470
22. Mood disorders in the medically ill: scientific review and recommendations. DL Evans DS Charney L Lewis RN Golden JM Gorman KR Krishnan CB Nemeroff JD Bremner RM Carney JC Coyne MR Delong N Frasure-Smith AH Glassman PW Gold I Grant L Gwyther G Ironson RL Johnson AM Kanner WJ Katon PG Kaufmann FJ Keefe T Ketter TP Laughren J Leserman CG Lyketsos WM McDonald BS McEwen AH Miller D Musselman C O'Connor JM Petitto BG Pollock RG Robinson SP Roose J Rowland Y Sheline DS Sheps G Simon D Spiegel A Stunkard T Sunderland P Tibbits Jr WJ Valvo, Biol Psychiatry 2005 58 175 189 10.1016/j.biopsych.2005.05.001 16084838
23. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. AA Nierenberg MM Husain MH Trivedi M Fava D Warden SR Wisniewski S Miyahara AJ Rush, Psychol Med 2009 40 41 50 10.1017/S0033291709006011 19460188
24. R Maller X Zhou, Survival Analysis with Long-Term Survivors Chichester: John Wily & Sons 1996